EuroPCR 2016: Polymer-free coronary stent more effective & safer than BMS in ACS patients

(PCR) Results from a prespecified sub-study of the LEADERS FREE trial in patients with acute coronary syndromes and high risk for bleeding show lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention with a polymer-free drug-coated stent than with a bare metal stent.

http://www.eurekalert.org/pub_releases/2016-05/p-e2p051616.php

Source: EurekAlert! - Medicine and Health - May 17, 2016 Category: Global & Universal Source Type: news